Evidence map›Paper›PMID 34150768›Full record

ReviewFrontiers in cell and developmental biology2021

Integrating High-Throughput Approaches and

Bum-Kyu Lee, Jonghwan Kim

Abstract readReview
In one paragraph

Review in Frontiers in cell and developmental biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Bum-Kyu LeeDepartment of Biomedical Sciences, Cancer Research Center, University at Albany-State University of New York, Rensselaer, NY, United States.
Jonghwan KimDepartment of Molecular Biosciences, Center for Systems and Synthetic Biology, The University of Texas at Austin, Austin, TX, United States.

Funding

Investigating regulators controlling differentiation potential of ES cellsR01GM112722 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI KIM, JONGHWAN · 2015 to 2023
$2.8M
Deciphering gene regulatory networks modulating human trophoblast stem cell self-renewal and differentiationR01HD101512 · NICHD · UNIVERSITY OF TEXAS AT AUSTIN · PI KIM, JONGHWAN · 2021 to 2025
$2.3M
NICHD NIH HHS R01 HD101512NIGMS NIH HHS R01 GM112722
6 · The paper itself

Abstract

The placenta is a temporary but pivotal organ for human pregnancy. It consists of multiple specialized trophoblast cell types originating from the trophectoderm of the blastocyst stage of the embryo. While impaired trophoblast differentiation results in pregnancy disorders affecting both mother and fetus, the molecular mechanisms underlying early human placenta development have been poorly understood, partially due to the limited access to developing human placentas and the lack of suitable human

Indexed as

epigenomeshuman placenta modelsomics approachesplacentatranscriptomestrophoblasttrophoblast stem cells

Identifiers

PMID34150768
PMCPMC8206641

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.